Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Treatment of autosomal dominant progressive hearing loss by in vivo delivery of genome editing agents

PROVIDER: PRJNA381788 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5419640.fastq.gz	Fastqsanger.gz
	SRR5419650.fastq.gz	Fastqsanger.gz
	SRR5419660.fastq.gz	Fastqsanger.gz
	SRR5419670.fastq.gz	Fastqsanger.gz
	SRR5419680.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 411

Similar Datasets

Project description:Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo

| PRJNA994108 | ENA

Project description:Allele-specific gene editing with S. aureus Cas9-KKH prevents deafness in a model of dominant progressive hearing loss

| PRJNA541170 | ENA

EGAS00001000001-sc-20120711 - samples

Project description:Progressive Hearing Loss

| EGAD00001000197 | EGA

Deafness Gene Expression Patterns in the Mouse Cochlea Found by Microarray Analysis

2014-01-08 | GSE53863 | GEO

Expression data of mice cochlea treated with L-methionine and valproic acid.

2015-04-15 | GSE62173 | GEO

Expression data of mice cochlea treated with L-methionine and valproic acid.

Project description:Treatment of DBA/2J mice with a combination of L-methionine and valproic acid significantly attenuated progressive hearing loss. We examined gene expression in the whole cochlea of the mice. This study was aimed to detect genes of which change in expression levels were associated with attenuation of progressive hearing loss in the mice. DBA/2J mice at 4 weeks old (untreated_4-weeks, N=5), mice treated with control vehicle (0.1M sodium bicarbonate) for 8 weeks (Control_vehicle_12-weeks, N=5), and mice treated with L-methionine and valproic acid (MET_and_VA_12-weeks, N=6) were analyzed.

2015-04-15 | E-GEOD-62173 | biostudies-arrayexpress

Exome Resequencing of Progressive Hearing Loss

Project description:Exome resequencing of progressive hearing loss.

| EGAS00001000001 | EGA

Therapeutic Restoration of miR-96 Prevents Hearing Loss in Mice through Modulation of Noise-Induced and Genetic Pathways

Project description:Hearing loss often arises from impairments in multiple genes, complicating therapeutic development. MicroRNAs, as master regulators, offer promising targets for complex diseases. We explored miR-96’s roles in hair cell (HC) function and noise-induced hearing loss (NIHL), finding that miR-96-/-, not miR-96+/-, mice exhibited progressive hearing loss due to gene regulatory network dysregulation from miR-96 loss in HCs not spiral ganglion neurons (SGNs). Viral-mediated delivery of miR-96 into the inner ear partially rescued hearing of miR-96-/- mice. Tamoxifen-induced depletion of miR-96 in adult UBCCreERT2/+; miR-96fl/fl mice led to hearing loss, with Bach2, Gabra2, Gabra4, Grk1 up-regulation, and Tnn, Col11a1, Gjb3 and Hnf4a down-regulation. Furthermore, noise trauma reduced miR-96, altering Bach2, Bcl2l1, Slc26a9, Gabrb1, Grk1, Nos2 and Cyp1a1 expression, while miR-96 overexpression protected hearing against noise by reversing the expression of Bach2, Bcl2l1 and Cyp1a1. Our findings underscore miR-96’s essential role in adult hearing maintenance and NIHL prevention, presenting it as a promising therapeutic target.

2025-04-21 | GSE247473 | GEO

Project description:A novel MYO6MYO6 variants identified in a Chinese family with autosomal dominant nonsyndromic hearing loss

| PRJNA1063509 | ENA

Deafness Gene Expression Patterns in the Mouse Cochlea Found by Microarray Analysis

Project description:This study demonstrates the baseline data of gradient gene expression in the cochlea. Especially for genes whose mutations cause autosomal dominant non syndromic hearing loss (Pou4f3, Slc17a8, Tmc1, and Crym) as well as genes important for cochlear function (Emilin-2 and Tectb), gradual expression changes help to explain the various pathological conditions. Four C57BL/6 mice aged 6 weeks cochlea samples including the lateral wall, stria vascularis, spiral ligament, spiral prominence, and the organ of corti were dissected and separated into the apical, middle and basal turns to compare gene expression profiles of each cochlea turn.

2014-01-08 | E-GEOD-53863 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data